{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T09:44:53Z","timestamp":1708508693151},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.lungcan.2013.04.006","type":"journal-article","created":{"date-parts":[[2013,4,29]],"date-time":"2013-04-29T15:45:44Z","timestamp":1367250344000},"page":"27-31","source":"Crossref","is-referenced-by-count":3,"title":["Identification of novel mutations of TP53, ALK and RET gene in metastatic thymic squamous cell carcinoma and its therapeutic implication"],"prefix":"10.1016","volume":"81","author":[{"given":"Zhenli","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinghan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruey-Long","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanlin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Yen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2013.04.006_bib0005","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejca.2007.11.004","article-title":"Thymic epithelial tumours: a population-based study of the incidence, diagnostic procedures and therapy","volume":"44","author":"de Jong","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0010","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","author":"Engels","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0015","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.humpath.2010.02.012","article-title":"World Health Organization classification of thymomas provides significant prognostic information for selected stage III patients: evidence from an international thymoma study group","volume":"41","author":"Marchevsky","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0020","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.athoracsur.2008.11.022","article-title":"Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis","volume":"87","author":"Korst","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0025","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1053\/j.semtcvs.2004.11.003","article-title":"Role of chemotherapy in the management of advanced thymic tumors","volume":"17","author":"Evans","year":"2005","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1023\/A:1024328215432","article-title":"Leptomeningeal metastases from recurrent squamous cell cancer of the skin","volume":"63","author":"Begemann","year":"2003","journal-title":"J Neurooncol"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0035","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1200\/JCO.2011.36.0487","article-title":"Thymic malignancies: from clinical management to targeted therapies","volume":"29","author":"Kelly","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0040","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1097\/JTO.0b013e3181f209b9","article-title":"Thymic tumors: relevant molecular data in the clinic","volume":"5","author":"Girard","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0045","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.athoracsur.2005.07.019","article-title":"Proposal of a novel system for the staging of thymic epithelial tumors","volume":"80","author":"Bedini","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0050","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1097\/00000478-200212000-00008","article-title":"Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumors","volume":"26","author":"Chalabreysse","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00000478-200101000-00012","article-title":"Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors","volume":"25","author":"Okumura","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0060","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2","article-title":"Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial","volume":"91","author":"Loehrer","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0065","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/JTO.0b013e3181db3dee","article-title":"Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience","volume":"5","author":"Grassin","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.lungcan.2010.09.011","article-title":"Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation","volume":"71","author":"Disel","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0075","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/(SICI)1097-0215(19960621)69:3<180::AID-IJC5>3.0.CO;2-W","article-title":"p53 expression and proliferative activity predict survival in non-invasive thymomas","volume":"69","author":"Pich","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0090","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1383-5742(98)00013-1","article-title":"Mutations that alter RNA splicing of the human HPRT gene: a review of the spectrum","volume":"411","author":"O\u2019Neill","year":"1998","journal-title":"Mutat Res"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0095","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1126\/science.8122112","article-title":"Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma","volume":"263","author":"Morris","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0110","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1158\/0008-5472.CAN-07-6186","article-title":"Genomic alterations of anaplastic lymphoma kinase may sensitize tumors to anaplastic lymphoma kinase inhibitors","volume":"68","author":"McDermott","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0115","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Kwak","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0120","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1073\/pnas.0609412103","article-title":"Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK","volume":"104","author":"Galkin","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0125","doi-asserted-by":"crossref","first-page":"7394","DOI":"10.1158\/1078-0432.CCR-11-1648","article-title":"ALK mutations conferring differential resistance to structurally diverse ALK inhibitors","volume":"17","author":"Heuckmann","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0092-8674(85)90115-1","article-title":"Activation of a novel human transforming gene, ret, by DNA rearrangement","volume":"42","author":"Takahashi","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0135","first-page":"1457","article-title":"High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma","volume":"4","author":"Bongarzone","year":"1989","journal-title":"Oncogene"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0140","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2006-0017","article-title":"RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors","volume":"27","author":"de Groot","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0145","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa020461","article-title":"Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors","volume":"347","author":"Demetri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0150","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1200\/JCO.2002.20.17.3568","article-title":"keeps finding new indications: successful treatment of dermatofibrosarcoma protuberans by targeted inhibition of the platelet-derived growth factor receptor","volume":"20","author":"Sawyers","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0155","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.bjc.6605740","article-title":"Sunitinib in metastatic thymic carcinomas: laboratory findings and initial clinical experience","volume":"103","author":"Strobel","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0160","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nrd2380","article-title":"Molecular basis for sunitinib efficacy and future clinical development","volume":"6","author":"Faivre","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0165","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2006.06.3602","article-title":"Sunitinib: from rational design to clinical efficacy","volume":"25","author":"Chow","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0170","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/jnci\/djj069","article-title":"BAY 43-9006 inhibition of oncogenic RET mutants","volume":"98","author":"Carlomagno","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.lungcan.2013.04.006_bib0175","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/leu.2011.168","article-title":"Hypoxia-microRNA-16 downregulation induces VEGF expression in anaplastic lymphoma kinase (ALK)-positive anaplastic large-cell lymphomas","volume":"25","author":"Dejean","year":"2011","journal-title":"Leukemia"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500213001530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500213001530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T12:54:22Z","timestamp":1539694462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500213001530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0169500213001530"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2013.04.006","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}